Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Karch, Andréa; b; c; 1; * | Llorens, Francb; d; 1 | Schmitz, Matthiasb; d | Arora, Amandeep Singhb; d | Zafar, Saimab | Lange, Peterb | Schmidt, Christianb | Zerr, Ingab; d
Affiliations: [a] Research Group Epidemiological and Statistical Methods (ESME), Department of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany | [b] National Reference Center for TSE, Clinical Dementia Center, University Medical School Göttingen, Göttingen, Germany | [c] German Center for Infection Research (DZIF), Hannover-Braunschweig site, Hannover, Germany | [d] German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany
Correspondence: [*] Correspondence to: André Karch, MD, Department of Epid-emiology, Helmholtz Centre for Infection Research, Inhoffenstr. 7, 38124 Braunschweig, Germany. Tel.: +49 531 6181 3113; E-mail: [email protected].
Note: [1] These authors contributed equally to this work.
Abstract: Background: Cerebrospinal fluid (CSF) biomarkers are routinely used for the differential diagnosis of rapidly progressive dementia, but are also affected by patients’ characteristics. Objective: To assess if stratification by age, sex, and genetic risk factors improves the accuracy of cerebrospinal fluid (CSF) biomarkers in patients with rapidly progressive dementia. Methods: 1,538 individuals with sporadic Creutzfeldt-Jakob disease (CJD), 173 with classic Alzheimer’s disease (cAD), 37 with rapidly progressive Alzheimer’s disease (rpAD), and 589 without signs of dementia were included in this retrospective diagnostic study. The effect of age, sex, PRNP codon 129, and APOE genotype on CSF levels of tau, p-tau, Aβ1–42, and Aβ1–40 values measured at time of diagnostic work-up was assessed. Results: Tau was a better marker for the differentiation of CJD and rpAD in older (AUC:0.97; 95% CI:0.96–1.00) than in younger (AUC:0.91; 95% CI:0.87–0.94) patients as tau levels increased with age in CJD patients, but not in rpAD patients. PRNP codon 129 and APOE genotype had complex effects on biomarkers in all diseases, making stratification by genotype a powerful tool. In females (AUC:0.78; 95% CI:0.65–0.91) and patients older than 70 (AUC:0.78; 95% CI:0.62–0.93), tau was able to differentiate with moderate accuracy between cAD and rpAD patients. Conclusion: Implementation of stratum-specific reference ranges improves the diagnostic accuracy of CSF biomarkers for the differential diagnosis of rapidly progressive dementia. Diagnostic criteria developed for this setting have to take this into account.
Keywords: Alzheimer’s disease, amyloid-beta, biomarker, cerebrospinal fluid, Creutzfeldt-Jakob disease, dementia, tau
DOI: 10.3233/JAD-160267
Journal: Journal of Alzheimer's Disease, vol. 54, no. 4, pp. 1385-1393, 2016
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]